Table 1.
Baseline demographic and clinical characteristics of the participants
| Participants Characteristics |
HIV (ART naive) |
HIV (ART treated) |
HIV/PTB (ART naive) |
HIV/PTB (ART treated) |
Healthy Controls |
| Number (n) | 21 | 14 | 21 | 25 | 21 |
| Female gender (%) | 9(43%) | 8(57%) | 15(71%) | 11(46%) | 11(55%) |
| Age (years) Median(IQR) | 31(22.5–39.0) | 39.5(27.5–48.0) | 32(27.5–37.5) | 38(32.50–45.5) | 30(27–33.0) |
| CD4(cells/µ;l) Median(IQR) | 87(26–247.5)* | 112(21.5–265.5)* | 82(23–152.5)* | 165(76.5–165.5)* | 870(708–1037) |
| ART duration (months) Median (IQR) | N/A | 17.50(11–66) | N/A | 11(9.50–36) | N/A |
Abbreviations definitions: ART=Antiretroviral therapy, HIV=Human immune deficiency syndrome, TB=Tuberculosis. Results are presented as percent (n) or Median (Interquartile range: IQR).
*
p<0.001
all in comparison with the reference group; N/A= not applicable